Deucravacitinib Impurities
Daicel’s deucravacitinib impurity standards support kinase inhibitor impurity control and analytical robustness.
References
FAQ's
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.







